Ceylon Hospitals 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Ceylon Hospitals.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Healthcare 수익 성장	18.8%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Ceylon Hospitals 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

COSE:CHL.X0000 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (LKR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
6/30/2024	9,189	419	194	1,449	N/A
3/31/2024	9,153	417	-62	1,725	N/A
12/31/2023	8,942	270	-1,003	774	N/A
9/30/2023	8,786	254	-1,602	654	N/A
6/30/2023	8,461	407	-1,959	594	N/A
3/31/2023	7,905	572	-2,110	108	N/A
12/31/2022	7,780	747	-1,527	412	N/A
9/30/2022	7,440	980	-843	761	N/A
6/30/2022	7,605	973	-24	1,169	N/A
3/31/2022	7,841	982	395	1,505	N/A
12/31/2021	7,581	906	1,165	1,950	N/A
9/30/2021	7,174	844	1,138	1,695	N/A
6/30/2021	6,528	775	839	1,314	N/A
3/31/2021	5,546	560	880	1,265	N/A
12/31/2020	5,133	453	75	744	N/A
9/30/2020	5,379	375	27	795	N/A
6/30/2020	5,481	332	-112	636	N/A
3/31/2020	5,976	403	-72	638	N/A
12/31/2019	6,064	405	96	737	N/A
9/30/2019	5,877	322	83	672	N/A
6/30/2019	5,766	292	110	815	N/A
3/31/2019	5,806	322	-10	854	N/A
12/31/2018	5,798	455	186	922	N/A
9/30/2018	5,684	412	186	945	N/A
6/30/2018	5,686	397	210	789	N/A
3/31/2018	5,733	402	N/A	911	N/A
12/31/2017	5,696	323	N/A	916	N/A
9/30/2017	5,623	320	N/A	749	N/A
6/30/2017	5,531	329	N/A	784	N/A
3/31/2017	5,289	328	N/A	709	N/A
12/31/2016	5,152	343	N/A	661	N/A
9/30/2016	5,078	400	N/A	801	N/A
6/30/2016	4,850	394	N/A	802	N/A
3/31/2016	4,728	429	N/A	849	N/A
12/31/2015	4,526	316	N/A	740	N/A
9/30/2015	4,379	274	N/A	637	N/A
6/30/2015	4,217	259	N/A	579	N/A
3/31/2015	4,083	200	N/A	527	N/A
12/31/2014	4,003	210	N/A	477	N/A
9/30/2014	3,905	190	N/A	459	N/A
6/30/2014	3,947	182	N/A	451	N/A
3/31/2014	3,961	192	N/A	425	N/A
12/31/2013	3,933	265	N/A	483	N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if CHL.X0000's forecast earnings growth is above the savings rate (3.7%).

수익 vs 시장: Insufficient data to determine if CHL.X0000's earnings are forecast to grow faster than the LK market

고성장 수익: Insufficient data to determine if CHL.X0000's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if CHL.X0000's revenue is forecast to grow faster than the LK market.

고성장 수익: Insufficient data to determine if CHL.X0000's revenue is forecast to grow faster than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: Insufficient data to determine if CHL.X0000's Return on Equity is forecast to be high in 3 years time

Ceylon Hospitals 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Recent updates

Full year 2024 earnings released: EPS: LK₨11.59 (vs LK₨16.88 in FY 2023)

New minor risk - Shareholder dilution

Full year 2024 earnings released: EPS: LK₨11.81 (vs LK₨16.88 in FY 2023)

Upcoming dividend of LK₨2.00 per share

New minor risk - Dividend sustainability

Ceylon Hospitals PLC has filed a Follow-on Equity Offering in the amount of LKR 549.905828 million.

Third quarter 2024 earnings released: EPS: LK₨2.80 (vs LK₨2.53 in 3Q 2023)

Ceylon Hospitals plc Announces Retirement of A.S. Abeywardena as Independent Non-Executive Director

Second quarter 2024 earnings released: EPS: LK₨2.74 (vs LK₨7.41 in 2Q 2023)

Investor sentiment deteriorates as stock falls 16%

Less than half of directors are independent

Ceylon Hospitals plc Appoints A.V.R. De Silva Jayatilleke as Deputy Chairman, Effective 1 November 2023

Investor sentiment improves as stock rises 18%

First quarter 2024 earnings released: EPS: LK₨0.54 (vs LK₨5.44 in 1Q 2023)

Full year 2023 earnings released: EPS: LK₨16.88 (vs LK₨29.00 in FY 2022)

Ceylon Hospitals PLC, Annual General Meeting, Jul 27, 2023

New minor risk - Share price stability

New minor risk - Shareholder dilution

Full year 2023 earnings released: EPS: LK₨16.71 (vs LK₨29.00 in FY 2022)

Upcoming dividend of LK₨2.30 per share at 4.8% yield

Third quarter 2023 earnings released: EPS: LK₨2.53 (vs LK₨9.41 in 3Q 2022)

Investor sentiment deteriorates as stock falls 15%

Insufficient new directors

First quarter 2023 earnings released: EPS: LK₨5.44 (vs LK₨5.72 in 1Q 2022)

Investor sentiment improved over the past week

Now 27% undervalued

Ceylon Hospitals PLC, Annual General Meeting, Jun 28, 2022

Full year 2022 earnings released: EPS: LK₨28.06 (vs LK₨16.54 in FY 2021)

Upcoming dividend of LK₨5.00 per share

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released

Less than half of directors are independent

Upcoming dividend of LK₨3.20 per share

Full year 2021 earnings released: EPS LK₨16.54 (vs LK₨11.91 in FY 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: LK₨103

New 90-day high: LK₨94.90

New 90-day high: LK₨84.00

New 90-day high - LK₨79.90

First quarter earnings released

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견